|
Disease management is vital to patient well-being and the reduction of overall medical cost. Throughout our disease state management (DSM) process, quality of care is foremost and cost, while important, is secondary. Rather than looking solely at immediate short-term cost implications, we evaluate the long-term results of therapy to determine its total cost.
Your employees with chronic illnesses will benefit from our hands-on approach to managing their disease, and your company will benefit from long-term control of drug costs. To ensure that each plan member has access to the best and most cost-effective pharmaceutical treatment available, we keep the lines of communication open by building relationships between patients, pharmacies and physicians. We’re quality outcomes oriented, provide the best care available for specific high-impact disease states and best of all, we guarantee our clinical management fees 100 percent.
Our ongoing management of diagnosed diseases includes:
- Evaluating non-drug therapy
- Evaluating the use and need for medication
- Recommending appropriate selection and dosage of medication
- Monitoring length of therapy
- Reevaluating medication selection based on outcomes
- Recommending combinations of medications, including step therapy
- Evaluating patient compliance with medication requirements
|